Menu Search
Equities

Edgewell Personal Care Co

EGZ:DUS

Edgewell Personal Care Co

Actions
  • Price (EUR)34.00
  • Today's Change1.00 / 3.03%
  • Shares traded200.00
  • 1 Year change+8.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Edgewell Personal Care Co's net income fell -14.04% from 114.70m to 98.60m despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 28.30% to 28.84%.
Gross margin43.09%
Net profit margin4.38%
Operating margin8.84%
Return on assets2.64%
Return on equity6.31%
Return on investment3.09%
More ▼

Cash flow in USDView more

In 2024, Edgewell Personal Care Co did not generate a significant amount of cash. However, the company earned 231.00m from its operations for a Cash Flow Margin of 10.25%. In addition the company used 62.40m on investing activities and also paid 179.40m in financing cash flows.
Cash flow per share3.73
Price/Cash flow per share9.14
Book value per share32.38
Tangible book value per share-14.37
More ▼

Balance sheet in USDView more

Edgewell Personal Care Co has a Debt to Total Capital ratio of 45.07%, a lower figure than the previous year's 88.33%.
Current ratio1.66
Quick ratio0.8139
Total debt/total equity0.8203
Total debt/total capital0.4507
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)31.03%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-11.19
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.